期刊文献+

p^(53)、P504S与Ki67在乳腺癌中的表达及意义 被引量:7

下载PDF
导出
摘要 乳腺癌是妇女最常见的恶性肿瘤之一,随着分子医学的发展,乳腺癌的研究已进入分子水平,现在人们己经认识到肿瘤是一种细胞周期调控异常的疾病。近几年来发现,p53基底细胞的特异性标记物,是判断良、恶性肿瘤的重要指标;P504S是前列腺癌标记物,在乳腺癌中也是高表达。可与良性肿瘤相鉴别;Ki67是应用最广泛的增殖细胞标志之一,可以根据其标记指数可以对良、恶性肿瘤进行鉴别,本研究采用免疫组化结合的方法,对30例乳腺癌和30例乳腺纤维瘤组织中的p^53、P504S和Ki67表达进行半定量分析.评价其在良、恶性乳腺病变鉴别诊断中的应用价值,为乳腺癌早期诊断、治疗提供理论依据。
出处 《黑龙江医药科学》 2012年第4期69-70,共2页 Heilongjiang Medicine and Pharmacy
  • 相关文献

参考文献12

  • 1Parki DM, Bray F, Ferlay J,et al. Global Cencer Statistics, 2002 [J]. CA Cancer J Clin,2005,55(2) :74-108.
  • 2Ling Yang,DMaxwell Patkin,Jacques Ferlay,et al. Esti--mates of- cancer incidence in China for 2000 and projections for 2005[J]. Can- cer Epidemiol Biomarkers . Prey, 2005, 14 (1) : 243-250.
  • 3Friedrichs K. Over expression of p53 and prognosis in breast cancer [J]. Cancer, 1993,72(12) :3641-3647.
  • 4姜军,陈意生,马宏敏,詹新恩,柳凤轩.p53蛋白在乳腺不典型增生和乳腺癌中的表达[J].第三军医大学学报,1998,20(1):63-64. 被引量:16
  • 5Lisboa BW, Vogtlander S, Gilster T, et al. Mileeular and immuno- histe chemical analysis of p53 mutations in serapings and tissue from perlnasive and invasive breast cancer [J]. Virchows Arch, 1997, 431:375.
  • 6左连富,齐风英,刘江惠,郭建文.乳腺癌P53基因蛋白的表达与临床预后的关系[J].癌症,1995,14(4):252-255. 被引量:13
  • 7Allred DG, Clark GM, Elledge R, et al. Ass(x;iation of p53 protein expression with tumor cell proliferation rate and clinical out come in node negative breast cancer[J]. JNCI, 1993,85:200-206.
  • 8Sato K, Ueda Y, Sakurai A, et al. Large ceil calcifying Sertoli cel tumor of the testis: comparative immunohistochemical study with Leydig cell tumor[J]. Pathol Int. 2005,55 : 366-371.
  • 9Katsuaki S, Hironori T, Shojiroh M, et al. Sertoli cell tumor of the testis, not otherwise specified, presenting extensive hemorrhage and overexpression of amethylacyl- CoA raeemase (AMACR/ PSOSs) [J]. Vrvh,2007,450:361-363.
  • 10Witkiewiez AK, Varambally S, Shen R, et al. Alpha--methylacyl --CoA racemase protein expression is associated with the degree of differentiation in breast cancer usiong quantitative image an alysis [J]. Cancer Epidemiol Biomarkers Prey,2005,14(4):8-1423.

二级参考文献16

  • 1姜军,陈意生,柳凤轩,詹新恩,马宏敏.乳腺不典型增生组织中ras基因产物表达的意义[J].第三军医大学学报,1996,18(3):202-205. 被引量:5
  • 2Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J]. Iht J Cancer, 1983,31 (1):13-20.
  • 3Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms [J]. J Pathol, 1990, 162(4): 285-294.
  • 4Mullerat J, Deroide F, Winslet MC, et al. Proliferation and p53expression in anal cancer precursor lesions [J]. Anticancer Res,2003, 23 (3C): 2995-2999.
  • 5Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations [J]. Head Neck,2003,25(4): 280-288.
  • 6Tut VM, Braithwaite AL, Angus B, et al. Gyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53,wafl, pRb and Ki67 [J]. Br J Gancer,2001, 84(2): 270-275.
  • 7Bhatavdekar JM, Patel DD, Shah NG,et al. Prognostic significance of immunohisto-chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis [J] . Ann Surg Oncol,2000, 7 (4): 305-311.
  • 8Vincent-Salomon A, Rousseau A, Jouve M, et al. Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy [J]. Eur J Cancer,2004(40): 1502-1508.
  • 9Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation [J]. Hum Pathol,2002,33(9): 863-870.
  • 10Norberg T, Klaar S, Kaff G, et al. Increased p53 nutation frequency during tumor progression-results from a breast cancer cohort [J]. Cancer Res, 2001, 61 (22): 8317-8321.

共引文献152

同被引文献53

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2Smith WL,Langenbach R.Why there are two cyclooxygenase isozymes [J].J Clin Invest,2001,107:1491-1495.
  • 3Bartek J,Iggo R,Caannon J,et al.Genetic and immuno-chemical analysis of mutant p53 in human breast cancer cell lines [J].Oncogene,1990,5(6):893-899.
  • 4曾加佳,王一安.中医情志疗法对乳腺癌术后化疗期患者生存质璧的影响[J].医学信息,2013:26(18):100-101.
  • 5Washington K.7th edition of the AJCC cancer staging manual:stomach[J].Ann Surg Oncol,2010,17:3077-3079.
  • 6Santiago JM,Sasako M,Osorio J.TNM-7th edition 2009(UICC/AJCC)and Japanese Classification 2010 in Gastric Cancer.Towards simplicity and standardisation in the management of gastric cancer[J].Cir Esp,2011,89:275-281.
  • 7Mayer B,Jauch K M,Gunthert U,et a1.De novoexpression of CD44and survival in gastric cancer[J].Lancet,1993,342(7):1019-1021.
  • 8王曼曼,孙华威,刘晔.乳腺癌影像学检查方法比较[J].黑龙江医药科学,2010,33(3):45-46. 被引量:9
  • 9黎增辉,廖爱军.JNK信号通路[J].国际病理科学与临床杂志,2010,30(3):273-276. 被引量:26
  • 10王新,许秋实,李壮,王博,周昱.乳腺癌COX-2、bFGF的表达及临床意义[J].黑龙江医药科学,2010,33(5):55-56. 被引量:5

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部